financetom
Business
financetom
/
Business
/
Universal Health Services Insider Sold Shares Worth $3,192,458, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Universal Health Services Insider Sold Shares Worth $3,192,458, According to a Recent SEC Filing
Jul 29, 2024 1:23 PM

04:12 PM EDT, 07/29/2024 (MT Newswires) -- Matthew Jay Peterson, Executive Vice President, UHS, on July 26, 2024, sold 15,141 shares in Universal Health Services ( UHS ) for $3,192,458. Following the Form 4 filing with the SEC, Peterson has control over a total of 5,253 shares of the company, with 5,253 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/352915/000112760224021085/xslF345X03/form4.xml

Price: 217.43, Change: -0.06, Percent Change: -0.03

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Consumer Stocks Mixed Premarket Thursday
Sector Update: Consumer Stocks Mixed Premarket Thursday
Oct 9, 2025
09:11 AM EDT, 10/09/2025 (MT Newswires) -- Consumer stocks were mixed premarket Thursday, with the Consumer Staples Select Sector SPDR Fund ( XLP ) 0.2% higher and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) down 0.2%. Ferrari (RACE) shares were down more than 12% after the company said at its capital markets day event that it was...
Form 8.3 - Just Group plc
Form 8.3 - Just Group plc
Oct 9, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Novo Nordisk To Acquire Liver Disease Focused Akero Therapeutics For Around $5 Billion
Novo Nordisk To Acquire Liver Disease Focused Akero Therapeutics For Around $5 Billion
Oct 9, 2025
Novo Nordisk A/S ( NVO ) agreed on Thursday to acquire Akero Therapeutics, Inc. ( AKRO ) focused on metabolic diseases. Transaction terms Novo Nordisk ( NVO ) will pay $54 per share in cash (or an aggregated value of $4.7 billion) at closing. In addition, Akero shareholders will receive a non-transferable CVR entitling holders to a potential additional payment...
Tariffs Shake Helen Of Troy With Big Profit Drop And Uncertain Future
Tariffs Shake Helen Of Troy With Big Profit Drop And Uncertain Future
Oct 9, 2025
Helen Of Troy Limited ( HELE ) shares plunged over 16% premarket Thursday after the company reported a sharp 51% drop in second-quarter adjusted earnings per share and warned of persistent cost pressures and tariff-related disruptions that are expected to weigh on results for the rest of fiscal 2026. Adjusted earnings per share tumbled 51.2% year-over-year (Y/Y) to 59 cents, beating...
Copyright 2023-2026 - www.financetom.com All Rights Reserved